Terapi Gen di Era Bioteknologi Modern: Aplikasi untuk Penyakit Genetik dan Non-Genetik

Nurlia Nurlia, Yusminah Hala


Abstract


The aim of this research is to explore the development of gene therapy in the era of modern biotechnology and analyze its application in the treatment of genetic and non-genetic diseases. The research uses the literature review method, which involves collecting, analyzing, and synthesizing relevant scientific sources to answer research questions. The research results obtained based on a literature approach, namely gene therapy in the era of modern biotechnology, have shown significant progress in the treatment of various genetic and non-genetic diseases. Technologies such as CRISPR-Cas9 enable high-precision DNA editing, which has been used to correct genetic mutations, while for non-genetic diseases, gene therapy has provided innovative solutions, such as engineered CAR-T cells and RNA interference (RNAi). Gene therapy still faces various challenges, including the risk of off-target mutations, the body's immune response, and ethical issues and high costs. Gene therapy, as a result of technological developments and research, is expected to be an important solution for various diseases that have been difficult to treat.

Keywords


Gene therapy, genetic, non-genetic

Full Text:

PDF

References


Amalia, A. Z. & Hilmi, N. (2024). Etika Pengobatan/Rekayasa Genetik dalam Islam sebagai Implikasi untuk Terapi Gen dan Teknologi DNA serta Tantangan Kontemporer. Jurnal Medika Nusantara, 2 (4), 56-64.

Angriani, W & Afdhal, F. (2024). Adeno-Associated Virus (AAV) Gene Therapy pada Hemofilia: A Systematic Review”. Majalah Kedokteran Andalas, 46 (9), 1482-1493.

Ardandi, R. Y., Nurhaliza, S., Poty, P. M., Sha, N. S., Himayani, R. & Rahmanisa, S. (2024). Penerapan DNA Rekombinan Dalam Terapi Gen: Vaksin DNA SARS-CoV-2 dan Terapi Kanker. Medula, 14 (5), 895-900.

Antero, J. (2023). Gene Therapy: A Promising Approach for Genetic Disorders. Annals of Clinical Trials and Vaccines Research, 13 (5), 152-153.

Bateman-House, A. (2024). Somatic Gene Therapy: Ethics and Access. Annual Review of Genomics and Human Genetics, 25 (1), 421–438.

Damara, F. A. (2017). CRISPR/Cas9 dengan Dual-sgRNAs Bertarget Gen E6 dan E7 Virus HPV 16 Sebagai Inovasi Terapi Gen Upaya Menurunkan Angka Kanker Serviks Global. Jurnal Scientific Pinisi, 3 (2), 98-103.

Elangkovan, N. & Dickson, G. (2021). Gene Therapy for Duchenne Muscular Dystrophy. Journal of Neuromuscular Diseases, 8 (2), 303–316.

Firdausy, D. A. M., Nofiana Ayu Risqiana Sari, N. A. R. & Lestarin, I. A. (2022). Potensi Terapi Genetik Berbasis Mesenchymal Beta-Stem Cell Secara Autologous pada Penderita Diabetes Melitus Tipe 1. Jurnal Kedokteran Unram, 11(2), 934-937.

Guiraud, S., Chen, H., Burns, D. T. & Davies, K. E. (2015). Advances in Genetic Therapeutic Strategies for Duchenne Muscular Dystrophy. Experimental Physiology, 100 (12), 1389-1494.

Guspratiwi, R. (2023). Terapi Gen: Era Baru dalam Pengobatan Kanker. Jurnal Ilmiah Multidisiplin Nusantara, 1 (2), 67-70.

Habibi, A., Risqiyani, S. Z., & Putri, D. A. S. (2021). Potensi Chimeric Antigen Receptor T Cell (CAR-T Cell) dengan Target Prostate-Specific Membrane Antigen (PSMA) Termodifikasi CRISPR/Cas9 sebagai Terapi Kanker Prostat. JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia, 9 (1), 23–37.

Henderson, M. L., Zieba, J. K., Li, X., Campbell, D.B.,Williams, M. R., Vogt, D. L., Bupp, C. P., Edgerly, Y. M., Rajasekaran, S., Hartog, N. L., Prokop, J. W. & Krueger, J. M. (2014). Gene Therapy for Genetic Syndromes: Understanding the Current State to Guide Future Care. BioTech, 13 (1), 1-31.

Imbert, M., Dias-Florencio, G., & Goyenvalle, A. (2017). Viral Vector-Mediated Antisense Therapy for Genetic Diseases. Genes, 8 (51), 1-19.

Kachroo, S., & Gowder, S. J. T. (2016). Gene therapy: An overview. Gene Technology, 5 (1).

Kelly, E. B. (2007). Gene Therapy. London: Greenwood Press.

Kim, Y., Landstrom, A. P., Shah, S. H., Wu, J. C., Seidman, C. E. & on Behalf of the American Heart Association. (2024). Gene Therapy in Cardiovascular Disease: Recent Advances and Future Directions in Science: A Science Advisory from the American Heart Association. Circulation, 150 (23), 471-480.

Kohn, L. A. & Kohn, D. B. (2021). Gene Therapies for Primary Immune Deficiencies. Front. Immunol, 12, 1-10.

Kurniawaty, E. (2017). Terapi Gen Miracle of Placenta. Bandar Lampung: AURA.

Misra, S. (2013). Human Gene Therapy: A Brief Overview of the Genetic Revolution. Journal of the Association of Physicians of India, 61 (2), 127-133.

Nayerossadat, N., Maedeh, T., & Ali, P. A. (2012). Viral and nonviral delivery systems for gene delivery. Advanced Biomedical Research, 1 (2), 1-11.

Negre, O., Eggimann, AV., Beuzard, Y., Ribeil, J. A., Bourget, P., Borwornpinyo, S., Hongeng, S., Hacein-Bey, S., Cavazzana, M., Leboulch, P. & Payen, E. (2016). Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the βA(T87Q)-Globin Gene. Human Gene Therapy, 27 (2),148-165.

Plasschaert, L.W., MacDonald, K. D. & Moffit, J. S. (2024). Current Landscape of Cystic Fibrosis Gene Therapy. Front. Pharmacol, (15), 1-15.

Putra, I. H., Khairunnisa, & M. Yusan Pratama, M. Y. (2023). Potensi Kombinasi Induced-Pluripotent Stem Cells (iPSC) dan Metode Pengeditan Gen Clustered Regularly Interspaced Short Palindromic Repeats–Associated Nuclease 9 (CRISPR-Cas9) Sebagai Terapi pada Pasien Hemofilia. Majalah Kedokteran Andalas, 46 (6), 1045-1055.

Sari, M. & Kasasiah, A. (2024). Pemanfaatan Teknologi CRISPR-CAS9 untuk Pengobatan Penyakit Huntington’s. Media Farmasi, 20 (2), 151-160.

Singh, S. P., Rai, K. A., Wal, P., Wal, A., Parveen, A., & Gupta, C. (2016). Gene Therapy: Recent Development in the Treatment of Various Diseases. International Journal of Pharmaceutical, Chemical, and Biological Sciences, 6 (2), 205-214.

Siregar, S. F. E., Putri, M. A., Salsabila, M. P., Putri, N. N. S., Sekarningrum, R. M. & Wasir, R. (2024). Etika dan Regulasi Terapi Gen dalam Praktik Medis. Jurnal Kesehatan Tambusai, 5 (4), 11492-11500.

Smith, J. E. (2009). Biotechnology. Fifth Edition. UK: Cambridge University Press.

Spencer, H. T., Riley, B. E. & Doering, C. B. (2016). State of the art: Gene Therapy of Haemophilia. Haemophilia, 22 (5), 66-71.

Wang, L., Li, F., Dang, L., Liang, C., Wang, C., He, B., Liu, J., Li, D., Wu, X., Xu, X., Lu, A., & Zhang, G. (2016). In Vivo Delivery Systems for Therapeutic Genome Editing. International Journal of Molecular Sciences, 17 (5), 1-19.

Widyastuti, D. A. (2017). Terapi Gen: Dari Bioteknologi untuk Kesehatan. Al-Kauniyah: Journal of Biology, 10 (1), 49-62.

Yuliani, H. E., Firdhiana, W. W., Ningrum, S. A., Vira, T. D., Khasanah, N. & Nurwahyunani, A. (2024). Terapi Gen Sebagai Alternatif Pengobatan Penyakit Kanker. Jurnal Salome: Multidisipliner Keilmuan, 2 (1), 46-58.




DOI: https://doi.org/10.30743/best.v7i2.10411

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.